Treg depletion is a possible strategy for enhancing CD8+ T-cell functionality in cancer patients, but as is mentioned above, it may strengthen viral persistence when such cases also have SARS-CoV-2-related infection (Figure 2). The gene discussed is CD8A; the disease is cancer.